← Back to searchRecruitingRecruiting
Type 2 Continuous Glucose Monitoring Academy
NCT06516640 · Children's Hospital Los Angeles
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Randomized Control Trial Evaluating the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes
About this study
The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D):
* The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies.
* The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics.
* The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics.
Participants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.
Eligibility criteria
Inclusion Criteria:
1. Current age of 8-21 years;
2. T2D diagnosis;
3. Able to speak, read, and write English or Spanish
Exclusion Criteria:
a. Known history of medical adhesive allergies;
Study design
Enrollment target: 60 participants
Allocation: randomized
Masking: none
Age groups: child, adult
Timeline
Starts: 2025-06-23
Estimated completion: 2026-12-30
Last updated: 2026-02-06
Interventions
Behavioral: Continuous Glucose Monitoring AcademyBehavioral: Standard Education
Primary outcomes
- • Mean change in Time in Range (TIR) from baseline to 6 months (Baseline to 6 months)
Sponsor
Children's Hospital Los Angeles · other
With: National Institute on Minority Health and Health Disparities (NIMHD)
Contacts & investigators
ContactNatalia Garban · contact · ngarban@chla.usc.edu · 3233611359
ContactRebecca Barber · contact · rbarber@chla.usc.edu · 3233611359
InvestigatorRebecca Barber, PhD, RN · principal_investigator, Children's Hospital Los Angeles
All locations (1)
Children's Hospital Los AngelesRecruiting
Los Angeles, California, United States